(INCY) Incyte - Performance 19.4% in 12m
INCY performance: live returns, drawdowns, peer ranking & SPY comparison from 1w to 5y, all in one clean chart-driven dashboard.
Performance Rating
-42.45%
#57 in Peer-Group
Rel. Strength
66.59%
#2565 in Stock-Universe
Total Return 12m
19.40%
#50 in Peer-Group
Total Return 5y
-36.50%
#49 in Peer-Group
| P/E | Value |
|---|---|
| P/E Trailing | 345 |
| P/E Forward | 11.6 |
| High / Low | USD |
|---|---|
| 52 Week High | 83.38 USD |
| 52 Week Low | 55.17 USD |
| Sentiment | Value |
|---|---|
| VRO Trend Strength +-100 | 55.11 |
| Buy/Sell Signal +-5 | 0.56 |
| Support / Resistance | Levels |
|---|---|
| Support | |
| Resistance |
12m Total Return: INCY (19.4%) vs XBI (-7%)
5y Drawdown (Underwater) Chart
Top Performer in Biotechnology
Overall best picks of Peer Group - Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability | EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| GILD NASDAQ Gilead Sciences |
3.23% | 73% | 77.8% | 22.7 | 13.6 | 0.23 | 28.3% | -3.71% |
| UTHR NASDAQ United Therapeutics |
-9.1% | -6.38% | 147% | 11.3 | 10.5 | 1.43 | 74.6% | 16.1% |
| AMGN NASDAQ Amgen |
3.91% | -0.97% | 36% | 25.4 | 13.4 | 0.93 | 0.60% | 41% |
| BIM PA Biomerieux |
1.34% | 27.6% | -4.82% | 33.1 | 25.8 | 1.55 | -38.5% | -25.1% |
| NBIX NASDAQ Neurocrine Biosciences |
3.69% | -7.17% | 1.14% | 43 | 24.8 | 0.27 | 18.7% | -34.3% |
| KMDA NASDAQ Kamada |
18.3% | 43% | -4.19% | 27.6 | 22.4 | 0.9 | 68.9% | 36.8% |
| PTCT NASDAQ PTC Therapeutics |
-4.03% | 58.7% | -9.25% | 7.71 | 6.26 | 0.81 | - | 68% |
| ERF PA Eurofins Scientific SE |
6.2% | 28.7% | 15.2% | 28.9 | 15.4 | 0.64 | -62.1% | -19.3% |
Performance Comparison: INCY vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for INCY
| Total Return (including Dividends) | INCY | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | 1.53% | 3.36% | 5.25% |
| 3 Months | 12.99% | 15.73% | 24.13% |
| 12 Months | 19.40% | -7.02% | 14.15% |
| 5 Years | -36.50% | -24.21% | 111.83% |
| Trend Score (consistency of price movement) | INCY | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | -8.2% | 4.4% | 81% |
| 3 Months | 90.4% | 78.8% | 96.9% |
| 12 Months | 1.2% | -85.8% | 44.9% |
| 5 Years | -72.4% | -52.6% | 84% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
|---|---|---|---|
| 1 Month | %th56.00 | -1.77% | -3.53% |
| 3 Month | %th47.00 | -2.37% | -8.97% |
| 12 Month | %th75.00 | 28.42% | 4.59% |
| 5 Years | %th77.00 | -16.21% | -70.02% |
FAQs
Does Incyte (INCY) outperform the market?
Yes,
over the last 12 months INCY made 19.40%, while its related Sector, the SPDR S&P Biotech (XBI) made -7.02%.
Over the last 3 months INCY made 12.99%, while XBI made 15.73%.
Performance Comparison INCY vs Indeces and Sectors
Above 0 means better perfomance compared to Symbol in this Timeframe
INCY vs. Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | -1.6% | -3.7% | -10.5% | 5% |
| US NASDAQ 100 | QQQ | -1.4% | -3.8% | -11.1% | 7% |
| German DAX 40 | DAX | 0.6% | 2.9% | -22.6% | -9% |
| Shanghai Shenzhen CSI 300 | CSI 300 | -1.4% | -1.7% | -13.9% | -1% |
| Hongkong Hang Seng | HSI | -1.2% | -4.5% | -29.9% | -19% |
| India NIFTY 50 | INDA | 0.3% | -1.9% | -10.8% | 20% |
| Brasil Bovespa | EWZ | -4% | -7.3% | -35.5% | 9% |
INCY vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | -0.2% | -4.4% | -14.6% | -5% |
| Consumer Discretionary | XLY | -1.1% | -1.6% | -2.8% | 2% |
| Consumer Staples | XLP | -1.9% | 0.9% | -12.1% | 11% |
| Energy | XLE | -1.9% | -5.5% | -6.4% | 20% |
| Financial | XLF | -2.3% | -3.6% | -15.4% | -11% |
| Health Care | XLV | -1.1% | -0.6% | -3.1% | 24% |
| Industrial | XLI | -1.7% | -2.7% | -18.3% | -6% |
| Materials | XLB | -3.8% | -2.8% | -15% | 13% |
| Real Estate | XLRE | -1.5% | 0.6% | -10.2% | 7% |
| Technology | XLK | -2.4% | -7.2% | -12.8% | 8% |
| Utilities | XLU | -0.5% | -0.3% | -13.7% | -4% |
| Aerospace & Defense | XAR | 0.5% | -5.5% | -29.1% | -30% |
| Biotech | XBI | -2.6% | -1.8% | 2.7% | 26% |
| Homebuilder | XHB | -4.1% | -5.5% | -3.3% | 14% |
| Retail | XRT | -4.1% | -3.5% | -6.2% | 8% |
INCY vs. Commodities
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Oil | USO | -2.5% | -6.91% | -2.08% | 27% |
| Natural Gas | UNG | 7.9% | 11.4% | 6.3% | 22% |
| Gold | GLD | -1.9% | 2.7% | -31.1% | -20% |
| Silver | SLV | -2.6% | -5.4% | -27.8% | 2% |
| Copper | CPER | -0.6% | -3.1% | -27.5% | 9% |
INCY vs. Bonds
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| iShares 20+ Years Bond | TLT | 0.2% | 0.5% | -7.1% | 21% |
| iShares High Yield Corp. Bond | HYG | -0.4% | -0.1% | -9.4% | 9% |